Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab

Ann Hematol. 2020 Apr;99(4):887-889. doi: 10.1007/s00277-020-03960-4. Epub 2020 Feb 12.

Authors

Fumiya Wada¹, Tadakazu Kondo², Momoko Nakamura¹, Kazuhisa Chonabayashi¹, Momoko Nishikori¹, Masakatsu Hishizawa¹, Kouhei Yamashita¹, Akifumi Takaori-Kondo¹

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho Sakyo-ku, Kyoto, 606-8507, Japan.
² Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho Sakyo-ku, Kyoto, 606-8507, Japan. [email protected].

PMID: 32052134
DOI: 10.1007/s00277-020-03960-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / administration & dosage*
Epstein-Barr Virus Infections / diagnostic imaging
Epstein-Barr Virus Infections / drug therapy*
Epstein-Barr Virus Infections / etiology
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / trends
Hodgkin Disease / diagnostic imaging
Hodgkin Disease / drug therapy*
Hodgkin Disease / etiology
Humans
Lymphoproliferative Disorders / diagnostic imaging
Lymphoproliferative Disorders / drug therapy*
Lymphoproliferative Disorders / etiology
Middle Aged
Nivolumab / administration & dosage*
Transplantation, Homologous / adverse effects
Transplantation, Homologous / trends
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Nivolumab